Trials / Completed
CompletedNCT05938699
Aqueous Humor Dynamics of NCX 470 Ophthalmic Solution
Aqueous Humor Dynamics of NCX 470 Ophthalmic Solution - A Double-Masked, Placebo-Controlled, Phase 3b Clinical Trial (Whistler)
- Status
- Completed
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 18 (actual)
- Sponsor
- Nicox Ophthalmics, Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
This is a double-masked, placebo-controlled study which will determine the action of NCX 470 ophthalmic solution, 0.1% on aqueous humor dynamic parameters in healthy volunteers or subjects with OHT.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | NCX 470 | NCX 470 0.1% vs Placebo |
| DRUG | Placebo | NCX 0.1% vs Placebo |
Timeline
- Start date
- 2023-12-12
- Primary completion
- 2025-03-17
- Completion
- 2025-03-17
- First posted
- 2023-07-10
- Last updated
- 2025-09-08
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT05938699. Inclusion in this directory is not an endorsement.